本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

7.02
+0.36005.41%
盘后7.020.00000.00%16:10 EST
成交量:5.64万
成交额:39.59万
市值:4,319.83万
市盈率:-0.72
高:7.31
开:6.65
低:6.64
收:6.66
52周最高:46.80
52周最低:3.76
股本:615.36万
流通股本:300.20万
量比:0.85
换手率:1.88%
股息:- -
股息率:- -
每股收益(TTM):-9.7606
每股收益(LYR):-20.9448
净资产收益率:-141.82%
总资产收益率:-54.70%
市净率:0.60
市盈率(LYR):-0.34

数据加载中...

2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/25

重要事件披露

Form 8-K - Current report
2023/11/23

SEC问询函

Form CORRESP - Correspondence
2023/11/23

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/06

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/18

重要事件披露

Form 8-K - Current report
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/03

重要事件披露

Form 8-K - Current report